Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00532311 · ClinicalTrials.gov registry record · Phase 3
Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia
A Phase 3 study, sponsored by Takeda.
- Terminated
- Registry status
- Phase 3
- Development phase
- 411
- Enrollment target
NCT00532311: Clinical Trial Phase 3 study, sponsored by Takeda.
NCT00532311 is a Phase 3 study that was terminated before completion, run by Takeda. The registered enrollment target is 411 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00532311, a Phase 3 study, was terminated before completion, sponsored by Takeda.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 411 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the efficacy of lapaquistat acetate, once daily (QD), taken with statins on cholesterol levels in subjects with hypercholesterolemia
Interventions
- DRUG Lapaquistat acetate and stable statin therapy
- DRUG Stable statin therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 411 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-04 |
| Phase | Phase 3 |
Why NCT00532311 stopped before completion
NCT00532311 is an interventional study that assigns participants to a tested intervention. The registered 411 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 2 interventions - of which Lapaquistat acetate and stable statin therapy is the first listed.
NCT00532311 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00532311 about?
NCT00532311 is a clinical study titled "Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia". The purpose of the study is to determine the efficacy of lapaquistat acetate, once daily (QD), taken with statins on cholesterol levels in subjects with hypercholesterolemia
What is the current status of trial NCT00532311?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 411 participants. The study started on 2007-07. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00532311?
The interventions under investigation include: Lapaquistat acetate and stable statin therapy (DRUG), Stable statin therapy (DRUG).
Who is sponsoring clinical trial NCT00532311?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00532311's enrollment target sits among peer trials
411 909th of 2000 higher than 1,092 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05993689 · 412 participants · NA
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
- NCT06699212 · 412 participants · Phase 3
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia